Stories of Survival in Africa
Patient Support & AdvocacyTreatment Access

Stories of Survival in Africa

[vc_video link=’https://www.youtube.com/watch?v=uSbC8UEsBXE’]

Thousands of patients are diagnosed with chronic myeloid leukaemia (CML) annually around the world. CML, like any other cancer, does not discriminate. It affects people from all regions and walks of life. However, unlike many other cancers, CML has an amazing story due to advancements made in its treatment in the last decade. It was only 15 years ago that a patient newly diagnosed with CML would have a prognosis of survival of less than 5 years with the treatments available at the time.

The story of CML goes hand in hand with how lives can be changed even in remote areas of the world once patients have access to the latest treatment, regardless of affordability. Each one of the three cancer survivors and advocates featured in the video want you to know that life and survival is dear to all, regardless of where you are from. They tell their individual stories of survival and are able to share it with us because they were given the gift of life when they so needed it. Now, they are able to give of themselves to other patients. Today we will be sharing the powerful stories of how access to treatment, especially in remote areas, can change the course of the relationship between disease and patient. We invite you to listen to these stories and call on you to join us and urge your respective governments to lay the pathway for access to treatment for all cancer patients and give the gift of life, hope and dignity that every patient deserves.

See All Articles

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • The GIPAP Program Detailed in the ASCO Journal of Global Oncology

    The GIPAP Program Detailed in the ASCO Journal of Global Oncology

    Last week ASCO launched the inaugural issue of the Journal of Global Oncology. This new open access, online journal focuses exclusively on cancer research, treatment, and the delivery of care in middle and low resource countries.

    Among the first seven articles, published on September 23rd, are original research, commentaries, and review articles, including a special article looking at the Glivec International Patient Assistance Program (GIPAP), authored by our CEO Pat Garcia-Gonzalez, MS, and others.

  • From Depot to Delivered: Expanding Access Through our Supply Chain

    From Depot to Delivered: Expanding Access Through our Supply Chain

    When a doctor requests treatment for a patient in an out-of-reach country, my job is to ensure medicine gets to that patient. Multiply this by 30,000 patients across 70+ countries, and our supply chain becomes a complex system of forecasting demand, requesting donations, shipping medicines, tracking product and confirming deliveries at each destination. I recently….

  • Shining a Light on Onward’s Compassion

    Shining a Light on Onward’s Compassion

    When Onward was first diagnosed with chronic myeloid leukemia (CML), he spent many sleepless nights thinking about his future. Now, 11 years later, he advocates and provides support for other people going through the same thing. “I am now living a normal life and enjoying my cycling, and gardening, and forgetting about CML, I only….